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1. Introduction
Estradiol exerts its physiological function by 2 main 
pathways: genomic, via the transcription of certain target 
genes, and nongenomic, which is independent of direct 
gene activation (Stormshak and Bishop, 2008; Yu and 
Chaudry, 2009). While genomic effects are quite well 
described (Chen et al., 2004; Vasudevan and Pfaff, 2008), 
nongenomic estradiol effects are insufficiently known and 
studied. In different brain regions estradiol affects, in a 
nongenomic manner, the growth of dendritic branches, 
activity of GABA receptors, and the concentration of 
sodium and potassium ions (Kelly et al., 2002; Kow 
et al., 2006; Vasudevan and Pfaff, 2008). Modulation 
of synaptosomal and mitochondrial Ca2+ transport, 
previously reported from our laboratory, also relates to 
rapid, nongenomic methods of estradiol action (Nikezic 
et al., 1996, 1997; Horvat et al., 2000, 2001; Petrovic et al., 
2005, 2011, 2012). The estradiol receptors (ERs) ERα and 
ERβ appear to be the key mediators of estradiol effects in 
the brain. They are primarily localized in the cytoplasm 
and nucleus, while small amounts of ER are associated 
with the cell membrane and organelles (Kisler et al., 2013). 
Both receptors are present in the mitochondrial matrix, 
being involved in different aspects of hormone influence. 
Acting through ERα, estradiol increases mitochondrial 
cytochrome c protein, mRNA, and mitochondrial aconitase 
activity in brain endothelial cells (Razmara et al., 2008). 
On the other hand, ERβ knockdown results in a lower 
resting mitochondrial membrane potential, an increase 
in resistance to oxidative stressors, and maintained ATP 
concentrations in primary hippocampal neurons (Yang et 
al., 2009). Results of our in vitro studies on mitochondria 
isolated from hippocampal synaptosomes strongly suggest 
the involvement of ER in estradiol-induced modulation of 
mitochondrial Ca2+ flux (Petrovic et al., 2011). However, 
obtained results do not exclude the possibility of direct 
hormone action through estrogen-specific binding 
sites (other than ERs) associated with mitochondrial 
membranes. We already reported that specific estradiol 
binding to synaptosomal mitochondria is involved in 
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extragenomic hormone action on mitochondrial and 
synaptosomal content of Ca2+ (Horvat et al., 2001). In 
addition, estradiol showed beneficial effects on fatty acid 
composition of membrane phospholipids (Petrovic et al., 
2014).
Calcium (Ca2+) transport across the plasma membrane 
and membranes of subcellular organelles plays a 
fundamental role in neuronal activity and functions, such 
as synaptogenesis, neurite outgrowth, neurotransmitter 
release, synaptic plasticity, and cell differentiation and 
apoptosis. Among others, dopamine metabolism in the 
caudate nucleus (NC) and the development of the auditory 
brain stem also depend on Ca2+ flux regulation (Etou et 
al., 1996; Hirtz et al., 2011). In these regions, as well as in 
whole brain tissue, compromised Ca2+ homeostasis leads 
to neuronal dysfunction and cell death, being connected 
with multiple CNS disorders (Carafoli, 2002). Due to 
specific Ca2+ transport mechanisms, ruthenium red (RR)-
sensitive uniporter for Ca2+ influx and mitochondrial Na+/
Ca2+ exchanger (mtNCX) for Ca2+ efflux mitochondria 
are organelles critical for Ca2+ buffering in neural cells. 
The large population of neuronal mitochondria can store 
and release relatively large amounts of calcium, leading to 
transient changes in the intracellular Ca2+ concentrations. 
Mitochondrial damage and disturbance of mitochondrial 
Ca2+ flux adversely affect the overall Ca2+ homeostasis in 
the brain (Szabadkai and Duchen, 2008).
The predominant Ca2+ efflux mechanism in 
synaptosomal mitochondria is the mtNCX. Estradiol was 
already found to inhibit mtNCX activity and consequently 
to decrease Ca2+ efflux from whole rat brain, hippocampal, 
NC, and brain stem (BS) synaptosomal mitochondria 
(Petrovic et al., 2012). Even more, the involvement of ER 
in Ca2+ efflux inhibition from hippocampal mitochondria 
has been confirmed (Petrovic et al., 2011). With this in 
mind, it was hypothesized that ER can be involved in 
transducing estradiol’s inhibitory effects on mitochondrial 
Ca2+ efflux in 2 other brain regions, the NC and BS. Thus, 
the aim of this study was to examine if, and to what 
extent, ERs participate in estradiol-induced inhibition of 
mitochondrial Ca2+ efflux in rat NC and BS.
2. Materials and methods
2.1. Animals 
Mature, chronically (3 weeks prior to use) ovariectomized 
female Wistar rats were used. The animals were obtained 
from the special animal breeding unit of our laboratory 
and maintained under constant conditions (lights on: 
0500–1700 hours, temperature: 24 °C, free access to 
food and water). All procedures were approved by the 
Ethics Committee of the Serbian Association for the 
Use of Animals in Research and Education and were in 
accordance with the guidelines published in the 1996 NIH 
Guide for the Care and Use of Laboratory Animals and 
the principles presented in the ‘Guidelines for the Use 
of Animals in Neuroscience Research by the Society for 
Neuroscience.
2.2. Isolation of synaptosomal mitochondria
After decapitation, whole brains were removed on ice. 
Synaptosomes were prepared from pools of NC and BS 
(10 NCs/pool and 10 BSs/pool). Purified synaptosomal 
mitochondria were isolated using a Ficoll gradient: 
4.5% and 6% resolved in medium containing 0.24 mol/L 
mannitol, 60 mmol/L sucrose, 50 µmol/L EDTA, and 
10 mmol/L Tris-HCl (pH 7.4), as described previously 
(Petrovic et al., 2011). Proteins were determined by the 
method of Lowry et al. (1951) as modified by Markwell et 
al. (1978). 
2.3. Pharmacological agents
45CaCl2 (specific activity: 16.8 mCi/mg) was purchased 
from PerkinElmer (USA). Cellulose nitrate filters (pore 
size: 0.45 µm) were from Whatman International (USA).
7α,17β-[9[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]
nonyl] estra-1,3,5(10)-triene-3,17-diol (ICI 182,780), 
4,4’,4’’-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol 
(PPT), 2,3-bis(4-hydroxy phenyl)-propionitrile (DPN), 
and 7-chloro-5-(2-chlorophenyl)-1,5-dihyhdro-4,1-
benzothiazepin-2(3H)-one (CGP) were obtained from 
Tocris Cookson Ltd. (USA). RR, 17β-estradiol (E2), 
17β-estradiol conjugated to bovine serum albumin 
(E-BSA), and other chemicals were purchased from Sigma 
Chemical Co. (USA). 
2.4. Mitochondrial Ca2+ transport
Ca2+ transport in mitochondria isolated from NC and 
BS synaptosomes was performed in the same conditions 
as already published (Petrovic et al., 2012). After 
preincubation at 23 °C for 10 min in a medium containing 
300 mmol/L mannitol, 10 mmol/L KCl, 1 mmol/L malate, 
5 mmol/L glutamate, and 10 mmol/l Tris-HCl (pH 7.4), 
mitochondria (0.2 mg protein/mL in a final volume of 300 
µL) were loaded with Ca2+ in the presence of 0.2 mol/L 
CaCl2 (0.6–0.75 µCi 
45CaCl2) for 5 min. Ca
2+ influx was 
stopped by RR (17.5 µg/mg protein), a specific inhibitor 
of the mitochondrial Ca2+-uniporter. Aliquots of 100 
µL in size were vacuum-filtered on 0.45-µm pore-size 
cellulose-nitrate filters. After being washed twice with 3 
mL of 0.25 M sucrose, the Ca2+ retained in mitochondria 
was calculated from radioactivity counting (corrected for 
blank without mitochondria and for nonspecific binding).
For Ca2+ efflux monitoring, mitochondria (0.2 mg 
protein/mL in the remaining volume of 200 µL) were 
incubated in the absence or presence of 0.5 nmol/L E2 or 
E-BSA (E2 concentration: 0.5 nmol/L) for an additional 
10 min. Ca2+ efflux was initiated by adding 100 mmol/L 
NaCl and 0.2 mmol/L EDTA and lasted for 5 min. 
PETROVIĆ et al. / Turk J Biol
330
The process was stopped with 2 mL of 0.25 M sucrose. 
Aliquots of 1 mL in size were vacuum-filtered and washed 
as described above. Na+-dependent Ca2+ efflux was 
calculated by subtracting the Ca2+ concentration retained 
in mitochondria after Na+/EDTA addition from the Ca2+ 
concentration in mitochondria after addition of RR.
The effects of the estrogen receptor antagonist (ICI 
182,780 (1 µmol/L)), ERα agonist (PPT (10 nmol/L)), 
ERβ agonist (DPN (10 nmol/L)), and mitochondrial Na+/
Ca2+ exchanger specific antagonist (CGP (10 µmol/L)) on 
Na+-dependent Ca2+ efflux in the presence and absence 
of E2 were measured by incubating Ca2+-preloaded 
mitochondria with ICI 182,780 for 20 min, PPT and DPN 
for 10 min, or CGP for 3 min before Na+/EDTA efflux 
initiation.
2.5. Statistical analysis
Changes in Ca2+ efflux observed after administering ICI 
182,780, PPT, DPN, or CGP were assessed by one-way 
ANOVA followed by Tukey’s post hoc test for intergroup 
comparison. The values represent the mean ± SEM of at 
least 3 experiments (with triplicate determinations). The 
differences were considered statistically significant at P < 
0.05.  
3. Results
3.1. Effect of ER antagonist ICI 182,780 on mitochondrial 
Ca2+ efflux inhibition 
The effects of ER antagonist ICI 182,780 on the inhibitory 
effect of E2 and E-BSA on Ca2+ efflux from NC and BS 
synaptosomal mitochondria are shown in Figure 1. In 
control conditions, Ca2+ efflux from NC mitochondria 
was 4.25 ± 0.28 nmol/mg protein. In the presence of E2, 
Ca2+ efflux was reduced to 2.51 ± 0.18 nmol/mg protein 
(P < 0.001, when comparing E2 to the control) and in the 
presence of E-BSA to 3.36 ± 0.26 nmol/mg protein (P < 
0.001 when comparing E-BSA to the control). Thus, E2 
inhibited Ca2+ efflux from NC mitochondria by 41% and 
E-BSA by 21%. When mitochondria were pretreated with 
ICI 182,780 before E2 or E-BSA addition, an increase of 
Ca2+ efflux could be seen when compared to E2 or E-BSA 
alone. Ca2+ efflux measured in the presence of ICI 182,780 
and E2 was 3.62 ± 0.26 nmol/mg protein (P < 0.001 when 
compared ICI + E2 to E2 alone) and in the presence of ICI 
182,780 and E-BSA was 4.08 ± 0.20 nmol/mg protein (P < 
0.001 when comparing ICI + E-BSA to E-BSA alone). Thus, 
pretreatment with ICI 182,780 decreased E2- and E-BSA-
induced inhibition of Ca2+ efflux from NC mitochondria 
by 64% and 81%, respectively. In the BS mitochondria, 
control Ca2+ efflux was 2.63 ± 0.22 nmol/mg protein, while 
E2 reduced this efflux to 1.66 ± 0.20 nmol/mg protein (P 
< 0.001 when comparing E2 to the control) and E-BSA to 
2.18 ± 0.13 nmol/mg protein (P < 0.001 when comparing 
E-BSA to the control). Thus, E2 inhibited Ca2+ efflux from 
BS mitochondria by 37% and E-BSA by 18%. As in NC 
mitochondria, pretreatment of BS mitochondria with ICI 
182,780 before E2 or E-BSA addition elevated Ca2+ efflux 
when compared to E2 or E-BSA alone. In the presence 
of ICI 182,780 and E2, Ca2+ efflux was 2.29 ± 0.16 nmol/
mg protein (P < 0.001 when comparing ICI + E2 to E2 
alone), and in the presence of ICI 182,780 and E-BSA, 
Ca2+ efflux was 2.52 ± 0.20 nmol/mg protein (P < 0.001 
when comparing ICI + E-BSA to E-BSA alone). Thus, ER 
antagonist ICI 182,780 diminished the inhibitory effect of 
E2 on Ca2+ efflux from BS mitochondria by 65% and E-BSA 
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Figure 1. Prevention of E2 and E-BSA inhibitory action on Ca2+ 
efflux by ER antagonist ICI 182,780: a) in NC mitochondria, b) in 
BS mitochondria. Ca2+-preloaded mitochondria were incubated 
for 20 min in the absence or presence of 1 µmol/L ER antagonist 
ICI 182,780 at 23 °C. Incubation continued for an additional 
10 min in the absence or presence of 0.5 nmol/L E2 or E-BSA 
(E2 concentration 0.5 nmol/L). Efflux was measured after 
the addition of 100 mmol/L NaCl and 0.2 mmol/l EDTA. The 
amount of released Ca2+ was estimated as indicated in Section 
2. One-way ANOVA followed by Tukey’s post hoc test showed 
significant decrease of Ca2+ efflux from mitochondria treated 
with E2 or E-BS when compared to the control (***P < 0.001) 
and significant increase of Ca2+ efflux when mitochondria were 
treated with ICI 182,780 before E2 or E-BSA addition (#P < 0.001, 
when comparing ICI + E2 to E2, and ICI + E-BSA to E-BSA). 
The results represent the mean ± SEM of 3 experiments (with 
triplicate determinations).
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the involvement of ER in E2 and E-BSA inhibitory action 
on mitochondrial Ca2+ efflux.
3.2. Effects of ERα agonist PPT and ERβ agonist DPN on 
mitochondrial Ca2+ efflux inhibition
To test the assumption about the involvement of ER in 
Ca2+ efflux inhibition and to examine the respective roles 
of ERα and ERβ, mitochondrial Ca2+ efflux was measured 
in the presence of a PPT-specific agonist of ERα and a 
DPN-specific agonist of ERβ (Figure 2). PPT decreased 
Ca2+ efflux from NC mitochondria by 10% (control Ca2+ 
efflux: 4.71 ± 0.26 nmol/mg protein; in the presence of 
PPT: 4.23 ± 0.17 nmol/mg protein; P < 0.05) and from 
BS mitochondria by 15% (control Ca2+ efflux: 2.36 ± 0.15 
nmol/mg protein; in the presence of PPT 2.01 ± 0.13 nmol/
mg protein; P < 0.01). The inhibitory effect of DPN was 
even stronger, reducing Ca2+ efflux from NC mitochondria 
by 25% (Ca2+ efflux in the presence of DPN 3.53 ± 0.1 
Ca2+/mg protein, P < 0.001 when compared to control) 
and from BS mitochondria by 21% (Ca2+ efflux in the 
presence of DPN 1.86 ± 0.17 Ca2+/mg protein, P < 0.001 
when compared to control). In mitochondria from both 
brain regions, NC and BS, the separate inhibitory potential 
of PPT or DPN was significantly lower when compared 
to E2, at P < 0.001. A significant difference between Ca2+ 
efflux in the presence of PPT and DPN was observed in 
NC mitochondria (P < 0.001). 
3.3. Effect of specific inhibitor of mitochondrial Na+/Ca2+ 
exchanger CGP 
In addition, both ER agonists expressed their effects 
in experiments with CGP, the specific inhibitor of 
mtNCX (Figure 3). CGP inhibited Ca2+ efflux from NC 
mitochondria by 94% (control Ca2+ efflux: 4.46 ± 0.22 
nmol/mg protein; in the presence of CGP: 0.27 ± 0.045 
nmol/mg protein; P < 0.001) and from BS mitochondria 
by 92% (control Ca2+ efflux: 2.51 ± 0.24 nmol/mg protein; 
in the presence of CGP 0.20 ± 0.075 nmol/mg protein; P < 
0.001). On the other hand, the incubation of mitochondria 
with ERβ agonist DPN before the addition of CGP 
increased Ca2+ efflux from NC mitochondria by 2.3-fold 
when compared with CGP alone. In the presence of DPN 
and CGP, Ca2+ efflux was 0.62 ± 0.057 nmol/mg protein 
(P < 0.001 when comparing DPN + CGP to CGP alone). 
Incubation of BS mitochondria with DPN before the 
addition of CGP increased Ca2+ efflux by 3.2-fold (0.64 ± 
0.081 nmol/mg protein) when compared with CGP alone 
(P < 0.001 when comparing DPN + CGP to CGP). ERα 
agonist PPT was less effective, with a 1.5-fold Ca2+ efflux 
increase from NC mitochondria, in the presence of CGP 
(0.4 ± 0.091 nmol/mg protein, P < 0.001 when comparing 
PPT + CGP to CGP) and almost no increase of efflux from 
BS mitochondria when compared with CGP alone. In 
mitochondria from both regions, a significant difference 
between Ca2+ efflux in the presence of PPT + CGP and 
DPN + CGP was observed at P < 0.001. 
4. Discussion
In the present study, the role of mitochondrial ER in E2-
induced inhibition of Ca2+ efflux from synaptosomal 
mitochondria isolated from rat brain NCs and BSs was 
evaluated by using specific ER antagonist ICI 182,780 and 
agonists PPT and DPN. We reported for the first time that 
both ERα and ERβ are involved in the inhibitory effect of E2 
on Ca2+ efflux from NC and BS synaptosomal mitochondria. 
Estradiol is well known to affect different aspects of 
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Figure 2. Involvement of ERα and/or ERβ in Ca2+ efflux 
modulation: a) in NC mitochondria, b) in BS mitochondria. 
Ca2+-preloaded mitochondria were incubated for 10 min in 
the absence or presence of 0.5 nmol/L E2, 10 nmol/L selective 
ERα agonist PPT, or 10 nmol/L selective ERβ agonist DPN at 
23 °C. Efflux was measured after the addition of 100 mmol/L 
NaCl and 0.2 mmol/L EDTA. The amount of released Ca2+ was 
estimated as indicated in Section 2. One-way ANOVA followed 
by Tukey’s post hoc test showed significant decrease of Ca2+ 
efflux from mitochondria treated with E2, PPT, or DPN when 
compared to the control (for NC mitochondria the significance 
was ***P < 0.001, **P < 0.05, *P < 0.001, respectively, and for BS 
mitochondria ***P < 0.001, **P < 0.01, *P < 0.001, respectively); 
significantly different Ca2+ efflux from PPT- or DPN-treated 
mitochondria when compared to E2-treated mitochondria (#P 
< 0.001); and significant decrease of Ca2+ efflux from DPN-
treated NC mitochondria when compared to PPT-treated NC 
mitochondria (XP < 0.001). The results represent the mean ± SEM 
of 3 experiments (with triplicate determinations).
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energetic efficiency, ATP supply, free radical defense 
system, and maintenance of Ca2+ homeostasis, E2 
contributes to the preservation of mitochondrial 
ultrastructure and membrane potential (Simpkins et al., 
2009; Richardson et al., 2012; Sastre-Serra et al., 2013). 
Even more, E2 is known to reverse the damage of neural 
cell mitochondria structure and ATP production caused 
by gonadal hormone deficiency (Xu et al., 2008). Since 
many of E2’s neuroprotective mechanisms converge 
upon mitochondria (Nilsen et al., 2003), any insight into 
the pathways of E2 effects on mitochondrial function, 
including their ability to accumulate and release Ca2+, 
could be of particular interest. As we previously reported, 
17β-estradiol acting in a nongenomic manner inhibits Ca2+ 
efflux from whole rat brain synaptosomal mitochondria, 
as well as from synaptosomal mitochondria isolated 
from specific brain regions: the hippocampus, NC, and 
BS (Horvat et al., 2001; Petrovic et al., 2011, 2012). There 
are 2 possible mechanisms of observed estradiol action: 
one going through ERα/β localized in the mitochondrial 
matrix (Chen et al., 2004; Psarra and Sekeris, 2009) and the 
other, non-ER mediated, going through estrogen-specific 
binding sites associated with mitochondrial membranes 
(Moss et al., 1997). Our recent results on hippocampal 
mitochondria speaking in favor of ER’s role in E2-induced 
inhibition of mitochondrial Ca2+ efflux in this brain region 
suggest that ER could be involved in transduction of E2 
effects in 2 other brain regions, the NC and BS.
As expected, when isolated NC and BS synaptosomal 
mitochondria were pretreated with ER antagonist ICI 
182,780 to prevent E2 binding to ER, the inhibitory 
effects of E2 and E-BSA on Ca2+ efflux were significantly 
decreased (65%–80%), highlighting an important role for 
ER in E2-induced modulation of mitochondrial Ca2+ flux. 
As seen in the literature, ICI 182,780 is a potent inhibitor 
of E2 action in the nervous system. Among others, 
treatment with ICI 182,780 blocks E2’s effects on P2X3 
receptor activity in sensory neurons (Ma et al., 2005), Akt1 
activity in hippocampal CA1 neurons (Yang et al., 2010), 
mitochondrial superoxide production in brain endothelial 
cells (Razmara et al., 2008), and mitochondrial dysfunction 
in astrocytes (Guo et al., 2012). Still, in our study, E2 and 
E-BSA kept between 20%–35% of their inhibitory potential 
even in the presence of ICI 182,780, suggesting that E2-
inhibition of mitochondrial Ca2+ efflux in the NC and BS 
could at least partially be due to hormone action through 
membrane binding-sites other than ERs. As previously 
reported, E2 binds to an oligomycin-sensitive subunit of 
the mitochondrial enzyme F0F1-ATPase (Ramirez et al., 
2001). Thus, by binding to such membrane-binding sites 
near mtNCX, E2 may indirectly disrupt the function of 
that transport protein. 
However, our experiments with selective ERα agonist 
PPT and ERβ agonist DPN confirmed the critical role 
of ER in E2 action observed in this study. Both agonists 
mimicked the inhibitory effect of E2 on Ca2+ efflux from 
NC and BS mitochondria, although they were less effective. 
On the other hand, DPN exerted stronger inhibitory 
potential than PPT, suggesting the dominant role of ERβ. 
In line with our results, ERβ mediated E2 reduction due 
to ischemic damage in the NC of ovariectomized mice 
(Carswell et al., 2004), while its agonist DPN decreased 
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Figure 3. Involvement of ERα and/or ERβ in Ca2+ efflux 
modulation by mitochondrial Na+/Ca2+ exchanger inhibitor 
CGP: a) in NC mitochondria, b) in BS mitochondria. Ca2+-
preloaded mitochondria were incubated for 10 min in the 
absence or presence of 10 nmol/L selective ERα agonist PPT 
or 10 nmol/L selective ERβ agonist DPN at 23 °C. Incubation 
continued for an additional 3 min in the absence or presence of 
10 µmol/L CGP. Efflux was measured after the addition of 100 
mmol/L NaCl and 0.2 mmol/L EDTA. The amount of released 
Ca2+ was determined as indicated in Section 2. One-way ANOVA 
followed by Tukey’s post hoc test showed significant decrease of 
Ca2+ efflux from mitochondria treated with CGP (***P < 0.001, 
when compared to the control), significant increase of Ca2+ efflux 
from mitochondria treated with PPT (only in NC mitochondria) 
or DPN before CGP addition when compared to CGP alone (#P < 
0.001), and significant increase of Ca2+ efflux from DPN + CGP-
treated mitochondria when compared to PPT + CGP-treated 
mitochondria (XP < 0.001). The results represent the mean ± SEM 
of 4 experiments (with triplicate determinations).
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the rostral ventrolateral medulla of the BS (Shih, 2009). 
Moreover, DPN enhances and PPT reduces ATP-evoked 
response in nociceptive trigeminal BS neurons (Tashiro et 
al., 2012). Further results in favor of ERβ were obtained 
in experiments with selective mtNCX inhibitor CGP. 
In our model system, Ca2+ efflux inhibition by CGP was 
almost complete (>90%) when compared to the control. 
In contrast to Ca2+ efflux inhibition by E2 in physiological 
conditions, pretreatment with E2 significantly increased 
mitochondrial Ca2+ efflux in the presence of CGP 
(Petrovic et al., 2012). Moreover, in the current study, 
in mitochondria isolated from both brain regions, DPN 
protected mtNCX activity against CGP’s inhibitory action 
in the same manner as E2, while ERα agonist PPT had a 
weaker effect on NC and no effect on BS mitochondria. 
The obtained results indicate for the first time that 
ERα and ERβ participate in E2-induced modulation of 
Ca2+ efflux from NC and BS synaptosomal mitochondria. 
A dominant role of ERβ has been shown in mitochondria 
from both brain regions. Since the experiments were 
performed in vitro on isolated mitochondria, these findings 
represent new evidence about genome-independent E2 
effects in specific brain regions. 
In summary, our study has shed light on the pathways 
through which estradiol regulates mitochondrial 
Ca2+ sequestration and consequently global cell Ca2+ 
homeostasis in the NC and BS. The role of ER has been 
confirmed. Considering the vital role of Ca2+ in regulation 
of total neural cell activity, from propagation of nerve 
impulse to cell metabolism and apoptosis, the effects on 
mitochondrial Ca2+ flux via ER could be the one of the 
important routes of estradiol neuromodulatory action in 
the brain.
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